## TERMS FOR PRIVATE PLACEMENT OF SERIES SEED PREFERRED STOCK OF [NAME OF COMPANY]

[date]

The following is a summary of the principal terms with respect to the proposed Series Seed Preferred Stock financing of [name of company], a Delaware corporation (the “*Company*”). Except for the section entitled “Binding Terms,” this summary of terms does not constitute a legally binding obligation. The parties intend to enter into a legally binding obligation only pursuant to definitive agreements to be negotiated and executed by the parties.

### Offering Terms

**Securities to Issue**: Shares of Series Seed Preferred Stock of the Company (the “*Series Seed*”).

**Aggregate Proceeds**: $____________ in the aggregate, of which $____________ will be invested by Bloomberg Beta.

**Purchasers**: Accredited investors approved by the Company (the “*Purchasers*”).

**Price Per Share**: Price per share (the “*Original Issue Price*”) will be based on a pre-money valuation of $____________, including in such pre-money valuation (i) any security convertible into, or exercisable for, capital stock of the Company, and (ii) an available option pool of ___ % of the Company’s post-money fully diluted shares. Bloomberg Beta will own no less than ___ % of the fully-diluted post-money capitalization after the final closing (assuming $____________ raise).

**Liquidation Preference**: One times the Original Issue Price plus declared but unpaid dividends on each share of Series Seed, balance of proceeds paid to Common. A merger, reorganization or similar transaction will be treated as a liquidation.

**Conversion**: Convertible into one share of Common (subject to proportional adjustments for stock splits, stock dividends and the like) at any time at the option of the holder.

**Voting Rights**: Votes together with the Common Stock on all matters on an as-converted basis.  Approval of a majority of the Preferred Stock required to (i) adversely change rights of the Preferred Stock; (ii) change the authorized number of shares; (iii) authorize a new series of Preferred Stock having rights senior to or on parity with the Preferred Stock; (iv) redeem or repurchase any shares (other than pursuant to employee or consultant agreements); (v) declare or pay any dividend; (vi) change the number of directors; (vii) liquidate or dissolve, including any change of control; or (viii) sell, issue, sponsor, create or distribute any digital tokens, blockchain-based assets, cryptocurrency or any other digital assets, including through a Simple Agreement for Future Tokens or other agreement, pre-sale, initial coin offering, token distribution event or crowdfunding.

**Documentation**: Documents will be based substantially on the Series Seed Preferred Stock documents published at [www.seriesseed.com](www.seriesseed.com), with the modifications set forth in this Term Sheet.

**Financial Information**: Purchasers who have invested at least $____________ (“*Major Purchasers*”) will receive standard information and inspection rights and management rights letter.

**Participation Right**: Major Purchasers will have the right to participate on a pro rata basis in subsequent issuances of equity securities.

**Board of Directors**: ___ director(s) elected by holders of a majority of common stock.

**Future Rights**: The Series Seed will be given the same rights as the next series of Preferred Stock (with appropriate adjustments for economic terms).

**Key Holder Matters**: Each Key Holder shall have four years vesting.  Full acceleration upon “Double Trigger.” The Company shall have a repurchase option on unvested shares at cost. Each Key Holder shall have assigned all relevant IP to the Company before closing. Each Key Holder will give the Company a right of first refusal in respect of any transfers of stock by such Key Holder, with a secondary right and right of over-allotment to Major Purchasers should the Company not exercise in full such right of first refusal.

**Binding Terms**: For a period of thirty days, the Company shall not solicit offers from other parties for any financing. Without the consent of Purchasers, the Company shall not disclose these terms to anyone other than officers, directors, key service providers, and other potential Purchasers in this financing.


***[COMPANY]***

BY: _____________________  
Name: _____________________  
Title: _____________________  
Date: _____________________

***BLOOMBERG BETA 2022 L.P.*** 

BY: _____________________  
Name: _____________________  
Title: Authorized Signatory  
Date: _____________________
